trial · primary record
Allopurinol
Tophaceous Gout
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 250 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Percentage of Participants with an sUA Level <5.0 mg/dL at Week 24 |
| Registry ID | NCT07089888 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:38.175Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07089888
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Allopurinol · compound